[Recurrent facial palsy, primary Gougerot-Sjögren's syndrome and vitamin B12 deficiency].
BACKGROUND
Differing cranial nerve involvement has been reported in the context of Gougerot-Sjögren's syndrome. Involvement of the V, III and VII nerves has been reported, the most characteristic being nerve V, notably its lower branch. Rare, well documented, cases of facial palsy have also been described.


METHODS
Recurrent facial palsy in a 40 year-old woman revealed a primary Sjögren's syndrome and vitamin B12 deficiency.


CONCLUSIONS
The onset of facial palsy has been linked with Gougerot-Sjögren's syndrome. The contribution of vitamin B12 deficiency is discussed.
Rousso
Emmanuel
E
Service de médecine interne, diabète et maladies métaboliques de la Clinique médicale B, Hôpitaux universitaires de Strasbourg.
Noel
Esther
E
Brogard
Jean-Marie
JM
Blicklé
Jean-Frédéric
JF
Andrès
Emmanuel
E
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D004576:Electromyography; D005158:Facial Paralysis / Q000209:etiology* / Q000534:rehabilitation; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D026741:Physical Therapy Modalities; D012008:Recurrence; D012859:Sjogren's Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D013967:Thyroiditis, Autoimmune / Q000150:complications; D016896:Treatment Outcome; D014805:Vitamin B 12 / Q000627:therapeutic use; D014806:Vitamin B 12 Deficiency / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D006886:Hydroxychloroquine; D014805:Vitamin B 12